Decision Resources announced today the release of its new report on Inflammatory Bowel Disease (IBD). The report forecasts that sales of pharmaceuticals to treat IBD will double between 2001 and 2011 in the major pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan).

(Photo: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION )

The report, Inflammatory Bowel Disease, highlights the major driving forces underlying the growth of the market. Some of these factors include:

  -- Continued market penetration of the tumor necrosis factor (TNF)      inhibitor infliximab, which will stem in part from its anticipated      approval as a maintenance therapy for Crohn's disease.   -- Market entry of other TNF inhibitors.   -- Introduction of other agents that target novel disease mechanisms and      offer new therapeutic alternatives to patients with refractory disease.   -- Replacement of older steroids by budesonide and emerging steroid      therapies.  

Inflammatory Bowel Disease offers invaluable market intelligence to pharmaceutical companies that are developing drugs to treat this disease. This study is part of Immune and Inflammatory Disorders, one of six Pharmacor services available from Decision Resources, Inc., which evaluate the commercial potential of drugs in research and development.

The study provides a thorough analysis of epidemiology, a review of medical practice, an assessment of current and emerging therapies, and an examination of unmet medical needs in the seven major pharmaceutical markets. The report also gives sales forecasts for specific compounds, supported by transparent logic based on in-depth interviews with physician experts and exhaustive secondary research.

About Decision Resources

Decision Resources, Inc. is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The Company has provided strategic information services for 30 years, assessing international pharmaceutical and health care industry trends. Visit Decision Resources at http://www.dresources.com/.

All company brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X43233276

NewsCom: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION

AP Archive: http://photoarchive.ap.org/

PRN Photo Desk, 888-776-6555 or 212-782-2840

SOURCE: Decision Resources, Inc.

Contact: Elizabeth Marshall of Decision Resources, +1-781-296-2563,
emarshall@dresource.com

Decision Resources, Inc., Launches Innovative Decision Support Tool for Metabolic Disorders

View Now